Immunoelectrophoretic studies on beta-1-E-globulin in human serum. 1967

S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011234 Precipitins Antibodies which elicit IMMUNOPRECIPITATION when combined with antigen. Immune Precipitates,Precipitates, Immune
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000362 Agar A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.

Related Publications

S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
June 1955, Journal of immunology (Baltimore, Md. : 1950),
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
May 1970, Klinische Wochenschrift,
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
November 1964, American journal of veterinary research,
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
June 1967, Turk Tip Cemiyeti mecmuasi,
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
December 1967, Biken journal,
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
February 1955, Journal of immunology (Baltimore, Md. : 1950),
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
January 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
April 1957, Klinische Wochenschrift,
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
May 1960, Clinica chimica acta; international journal of clinical chemistry,
S Hiramatsu, and K Nagaki, and S Inai, and S Tanabe
February 1965, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!